[HTML][HTML] Statins: a repurposed drug to fight cancer

W Jiang, JW Hu, XR He, WL Jin, XY He - Journal of Experimental & …, 2021 - Springer
As competitive HMG-CoA reductase (HMGCR) inhibitors, statins not only reduce cholesterol
and improve cardiovascular risk, but also exhibit pleiotropic effects that are independent of …

[HTML][HTML] Influence of cholesterol on cancer progression and therapy

SS Mayengbam, A Singh, AD Pillai, MK Bhat - Translational oncology, 2021 - Elsevier
Cholesterol is a fundamental molecule necessary for the maintenance of cell structure and is
vital to various normal biological functions. It is a key factor in lifestyle-related diseases …

[HTML][HTML] PCSK9 and cancer: Rethinking the link

K Mahboobnia, M Pirro, E Marini, F Grignani… - Biomedicine & …, 2021 - Elsevier
Background Cancer is emerging as a major problem globally, as it accounts for the second
cause of death despite medical advances. According to epidemiological and basic studies …

[HTML][HTML] Unraveling the anticancer potential of statins: Mechanisms and clinical significance

MY Zaky, C Fan, H Zhang, XF Sun - Cancers, 2023 - mdpi.com
Simple Summary Statins are crucial for managing lipid disorders by inhibiting HMG-CoA
reductase, reducing cholesterol levels, and lowering cardiovascular disease risk. Beyond …

[HTML][HTML] Regulation and targeting of SREBP-1 in hepatocellular carcinoma

F Su, A Koeberle - Cancer and Metastasis Reviews, 2023 - Springer
Hepatocellular carcinoma (HCC) is an increasing burden on global public health and is
associated with enhanced lipogenesis, fatty acid uptake, and lipid metabolic …

Beyond cholesterol metabolism: the pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for …

A Cesaro, V Bianconi, F Gragnano, E Moscarella… - Biofactors, 2020 - Wiley Online Library
Proprotein convertase subtilisin/kexin type 9 (PCSK9) has a crucial role in lipid metabolism,
particularly due to its function in low‐density lipoprotein receptor degradation. Gain‐of …

Pseurotin A as a novel suppressor of hormone dependent breast cancer progression and recurrence by inhibiting PCSK9 secretion and interaction with LDL receptor

KS Abdelwahed, AB Siddique, MM Mohyeldin… - Pharmacological …, 2020 - Elsevier
Hypercholesterolemia has been documented to drive hormone-dependent breast cancer
(BC) progression and resistance to hormonal therapy. Proprotein convertase subtilisin/kexin …

[HTML][HTML] Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma

J Tang, X Peng, D Xiao, S Liu, Y Tao, L Shu - Cancer Cell International, 2024 - Springer
Background Disulfidptosis is a type of programmed cell death caused by excessive cysteine-
induced disulfide bond denaturation leading to actin collapse. Liver cancer has a poor …

[HTML][HTML] The pivotal role of the dysregulation of cholesterol homeostasis in cancer: implications for therapeutic targets

EHK Mok, TKW Lee - Cancers, 2020 - mdpi.com
Cholesterol plays an important role in cellular homeostasis by maintaining the rigidity of cell
membranes, providing a medium for signaling transduction, and being converted into other …

[HTML][HTML] Association of serum anti-PCSK9 antibody levels with favorable postoperative prognosis in esophageal cancer

M Ito, T Hiwasa, Y Oshima, S Yajima, T Suzuki… - Frontiers in …, 2021 - frontiersin.org
Background Esophageal cancer often appears as postoperative metastasis or recurrence
after radical surgery. Although we had previously reported that serum programmed cell …